Maria Apigo, MD
Obstetrics & Gynecology · Glendale, AZNPI 1306836408
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 151 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $751 and has fallen 64.7% since, to $265 in 2025.
Across 151 payments — averaging $19.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$525
- Daiichi Sankyo Inc.$397
- Organon$157
- Mayne Pharma Commercial LLC$138
- Therapeuticsmd, Inc.$132
- Coopersurgical, Inc.$124
- plus $1K from 34 others
What the payments were for
- Food & beverage$2,86599%
- Education$261%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 21 | $525 |
| Daiichi Sankyo Inc. | 22 | $397 |
| Organon | 8 | $157 |
| Mayne Pharma Commercial LLC | 7 | $138 |
| Therapeuticsmd, Inc. | 8 | $132 |
| Coopersurgical, Inc. | 7 | $124 |
| Exeltis, USA Inc. | 8 | $116 |
| Bayer | 7 | $109 |
| Aspira Women's Health Inc | 5 | $99 |
| Hologic Sales And Service, LLC | 4 | $95 |
| Astellas Pharma US Inc | 3 | $72 |
| Millicent US Inc | 4 | $71 |
| Avion Pharmaceuticals | 4 | $61 |
| Biogen | 2 | $57 |
| Lupin Inc. | 4 | $56 |
| AMAG Pharmaceuticals, Inc. | 3 | $52 |
| Merck | 3 | $51 |
| Channel Medsystems, Inc. | 1 | $51 |
| Duchesnay USA Incorporated | 2 | $48 |
| Evofem Biosciences, Inc. | 3 | $46 |
| Mylan Pharmaceuticals Inc. | 3 | $45 |
| Ultragenyx Pharmaceutical Inc. | 2 | $36 |
| BD | 2 | $35 |
| Minerva Surgical, Inc | 2 | $35 |
| Vertex | 1 | $26 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Axonics, Inc. | 1 | $21 |
| Johnson & Johnson | 1 | $21 |
| Shield Therapeutics Inc | 1 | $20 |
| Medicem Inc. | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
| Pfizer | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| KCI USA, Inc. | 1 | $16 |
| Optumhealth Care Solutions, LLC | 1 | $16 |
| Covidien LP | 1 | $15 |
| Cook Medical LLC | 1 | $15 |
| Agile Therapeutics, Inc. | 1 | $15 |
| Myovant Sciences Inc. | 1 | $14 |
| AstraZeneca | 1 | $12 |
How this compares
$2,890 in reported general payments places this provider in the 80th percentile of 757 obstetrics & gynecology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other obstetrics & gynecology in Glendale
- Lee KoonGlendale$36K
- Catherine BrainardTucson$302K
- Micah HarrisScottsdale$217K
- Steven NelsonPhoenix$159K
- Ernesto GomezMesa$145K
- Bj HoPhoenix$134K
- Chijioke SoribePhoenix$117K
- Shruti BalaTucson$108K
- Heather ZechmanPhoenix$92K
- David GlassmanPhoenix$90K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.